AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

PharmaCyte Biotech, Inc.

$0.45 -$0.29 (-39.00%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$0.44
Day Range
$0.43$0.47
Year Range
$0.43$1.51
Market Cap
4.83M
AVG Volume
163.78K
Trailing/Forward PE
-0.15/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Net Income (USD) · TTM
-20M020M40M24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
PMCB Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q4-19.42M
26 Q3-3.28M
26 Q2-7.07M
26 Q1-1.13M
25 Q430.66M
25 Q320.25M
25 Q222.68M
25 Q126.94M
24 Q4334K
24 Q3-1.14M
Operating Income (USD) · TTM
-10M-7.5M-5M-2.5M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
PMCB Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q4-6.85M
26 Q3-5.38M
26 Q2-4.23M
26 Q1-3.96M
25 Q4-4.38M
25 Q3-6.5M
25 Q2-7.41M
25 Q1-7.71M
24 Q4-8.52M
24 Q3-6.26M
EBITDA (USD) · TTM
-6M-4M-2M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
PMCB EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q4-5.3M
26 Q3-5.38M
26 Q2-4.23M
26 Q1-3.96M
25 Q4-4.38M
25 Q3-1.99M
25 Q2-2.9M
25 Q1-3.2M
24 Q4-4.01M
24 Q3-5.48M
Cash Flows (USD) · TTM
-6M-4M-2M024 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
PMCB Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q4-5.15M
26 Q3-4.8M
26 Q2-4.52M
26 Q1-4.6M
25 Q4-2.98M
25 Q3-2.27M
25 Q2-1.94M
25 Q1-2.87M
24 Q4-2.15M
24 Q3-2.11M
EPS (USD) · TTM
-4-202424 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
PMCB EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q4-3.1
26 Q3-1.06
26 Q2-1.33
26 Q1-0.3
25 Q43.11
25 Q31.23
25 Q21.02
25 Q10.97
24 Q4-1.82
24 Q3-1.54
Expenses (USD) · TTM
02M4M6M8MR&DSG&A24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
PMCB Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q45.3M
26 Q36.29M
26 Q25.13M
26 Q14.86M
25 Q45.28M
25 Q34.5M
25 Q25.41M
25 Q15.71M
24 Q46.52M
24 Q36.26M
Shares Outstanding (USD) · TTM
-20M020M40M60MBuybacks (Repurchases)Stock-Based Compensation24 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q226 Q326 Q4
PMCB Shares Outstanding (USD) · TTM by quarter
PeriodShares Outstanding (USD) · TTM
26 Q4-726.93K
26 Q3-340.9K
26 Q23.92M
26 Q114.54M
25 Q424.55M
25 Q335.14M
25 Q237.63M
25 Q127.18M
24 Q443.68M
24 Q337.29M
Employee Count
012342017201820192020202120222023202420252026
PMCB Employee Count by quarter
PeriodEmployee Count
20262
20252
20242
20232
20224
20214
20204
20194
20184
20174
PE Ratio
0204060med 0.48Aug 24Nov 24Jan 25Mar 25May 25Jul 25Sep 25
PMCB PE Ratio by quarter
PeriodPE Ratio
Sep 250.23
Sep 250.21
Aug 250.21
Aug 250.22
Aug 250.2
Aug 250.29
Aug 250.34
Jul 250.33
Jul 250.35
Jul 250.37
Jul 250.38
Jun 250.35
Jun 250.36
Jun 250.35
Jun 250.35
May 250.35
May 250.36
May 250.36
May 250.38
May 250.42
Apr 250.42
Apr 250.41
Apr 250.42
Apr 250.43
Mar 250.45
Mar 250.54
Mar 250.48
Mar 250.54
Feb 250.54
Feb 250.54
Feb 250.5
Feb 250.46
Jan 250.49
Jan 250.5
Jan 250.52
Jan 250.47
Jan 250.5
Dec 240.48
Dec 240.5
Dec 240.53
Dec 240.48
Nov 240.5
Nov 240.5
Nov 240.48
Nov 240.53
Nov 240.53
Oct 240.53
Oct 240.5
Oct 240.51
Oct 240.52
Sep 240.54
Sep 240.47
Sep 2445.73
Sep 2438.26
Aug 2436.82
Aug 2439.95
Aug 2445.24
Free Cash Flow Yield
-200%-150%-100%-50%0%med -65.72%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PMCB Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-119.12%
Sep 26-110.23%
Aug 26-104.13%
Aug 26-100.61%
Aug 26-97.32%
Aug 26-90.88%
Jul 26-93.1%
Jul 26-179.97%
Jul 26-170.62%
Jul 26-155.06%
Jul 26-151.05%
Jun 26-140.32%
Jun 26-150.46%
Jun 26-141.92%
Jun 26-154.29%
May 26-129.44%
May 26-133.34%
May 26-134.27%
May 26-142.9%
May 26-142.99%
Apr 26-149.53%
Apr 26-148.23%
Apr 26-165.37%
Apr 26-156.53%
Mar 26-152.55%
Mar 26-157.26%
Mar 26-109.44%
Mar 26-100.31%
Feb 26-109.45%
Feb 26-107.52%
Feb 26-110.98%
Feb 26-101.91%
Jan 26-92.23%
Jan 26-80.53%
Jan 26-84.86%
Jan 26-85.69%
Jan 26-102.35%
Dec 25-106.37%
Dec 25-88.08%
Dec 25-66.35%
Dec 25-55.48%
Nov 25-87.49%
Nov 25-104.13%
Nov 25-86%
Nov 25-79.44%
Oct 25-72.78%
Oct 25-69.28%
Oct 25-69.83%
Oct 25-67.68%
Oct 25-65.08%
Sep 25-69.78%
Sep 25-69.06%
Sep 25-41.78%
Sep 25-46.17%
Aug 25-46.27%
Aug 25-44.79%
Aug 25-48.28%
Aug 25-39.31%
Aug 25-32.63%
Jul 25-34.17%
Jul 25-31.68%
Jul 25-30.21%
Jul 25-29.39%
Jun 25-31.68%
Jun 25-30.78%
Jun 25-32.3%
Jun 25-31.99%
May 25-31.68%
May 25-31.07%
May 25-30.78%
May 25-29.39%
May 25-26.96%
Apr 25-26.74%
Apr 25-27.42%
Apr 25-26.53%
Apr 25-26.31%
Mar 25-24.72%
Mar 25-20.65%
Mar 25-17.67%
Mar 25-15.68%
Feb 25-15.86%
Feb 25-15.86%
Feb 25-17.13%
Feb 25-18.74%
Jan 25-17.45%
Jan 25-17.13%
Jan 25-16.52%
Jan 25-18.37%
Jan 25-17.02%
Dec 24-17.78%
Dec 24-17.02%
Dec 24-16.23%
Dec 24-22.23%
Nov 24-21.32%
Nov 24-21.44%
Nov 24-22.23%
Nov 24-20.25%
Nov 24-19.92%
Oct 24-20.25%
Oct 24-21.32%
EV/EBITDA
-600-400-2000200med -262.15Aug 21Oct 21Dec 21Feb 22Apr 22May 22Jul 22
PMCB EV/EBITDA by quarter
PeriodEV/EBITDA
Jul 22-237.34
Jul 22-241.85
Jul 22-249.37
Jul 22-264.4
Jun 22-273.42
Jun 22-279.44
Jun 22-285.45
Jun 22-271.92
May 22-265.91
May 22-267.41
May 22-274.93
May 22-267.41
Apr 22-250.87
Apr 22-277.93
Apr 22-268.91
Apr 22-264.4
Apr 22-259.89
Mar 22-243.36
Mar 22-244.86
Mar 22-498.46
Mar 22-484.42
Feb 22-519.54
Feb 22-526.56
Feb 22-505.49
Feb 22-510.76
Jan 22-512.51
Jan 22-519.54
Jan 22-454.56
Jan 22-444.03
Dec 21-440.52
Dec 21-407.15
Dec 21-445.78
Dec 2141.58
Dec 2139.41
Nov 2141.14
Nov 2143.53
Nov 2148.3
Nov 2150.47
Oct 2148.08
Oct 2146.56
Oct 2152.85
Oct 2156.11
Oct 2155.89
Sep 2158.49
Sep 2165
Sep 2146.48
Sep 2142.42
Aug 2144.34
Aug 2144.13
Aug 2139.65
Price to Book
00.10.20.3med 0.15Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
PMCB Price to Book by quarter
PeriodPrice to Book
Sep 260.12
Sep 260.13
Aug 260.14
Aug 260.15
Aug 260.15
Aug 260.16
Jul 260.16
Jul 260.07
Jul 260.07
Jul 260.08
Jul 260.08
Jun 260.09
Jun 260.08
Jun 260.09
Jun 260.08
May 260.09
May 260.09
May 260.09
May 260.09
May 260.09
Apr 260.08
Apr 260.08
Apr 260.07
Apr 260.08
Mar 260.08
Mar 260.08
Mar 260.11
Mar 260.12
Feb 260.11
Feb 260.12
Feb 260.11
Feb 260.12
Jan 260.13
Jan 260.15
Jan 260.15
Jan 260.14
Jan 260.12
Dec 250.12
Dec 250.14
Dec 250.16
Dec 250.19
Nov 250.12
Nov 250.1
Nov 250.12
Nov 250.13
Oct 250.14
Oct 250.15
Oct 250.15
Oct 250.16
Oct 250.16
Sep 250.15
Sep 250.15
Sep 250.14
Sep 250.12
Aug 250.12
Aug 250.13
Aug 250.12
Aug 250.14
Aug 250.17
Jul 250.17
Jul 250.18
Jul 250.19
Jul 250.19
Jun 250.18
Jun 250.18
Jun 250.17
Jun 250.18
May 250.18
May 250.18
May 250.18
May 250.19
May 250.21
Apr 250.21
Apr 250.21
Apr 250.21
Apr 250.21
Mar 250.23
Mar 250.27
Mar 250.25
Mar 250.28
Feb 250.28
Feb 250.28
Feb 250.26
Feb 250.24
Jan 250.26
Jan 250.26
Jan 250.27
Jan 250.24
Jan 250.26
Dec 240.25
Dec 240.26
Dec 240.27
Dec 240.24
Nov 240.25
Nov 240.25
Nov 240.24
Nov 240.27
Nov 240.27
Oct 240.27
Oct 240.25
PharmaCyte Biotech, Inc.
PMCB
Stockpicker

Video analysis: PMCB

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.